SG47030A1 - Thrombopoietin - Google Patents

Thrombopoietin

Info

Publication number
SG47030A1
SG47030A1 SG1996003050A SG1996003050A SG47030A1 SG 47030 A1 SG47030 A1 SG 47030A1 SG 1996003050 A SG1996003050 A SG 1996003050A SG 1996003050 A SG1996003050 A SG 1996003050A SG 47030 A1 SG47030 A1 SG 47030A1
Authority
SG
Singapore
Prior art keywords
thrombopoietin
Prior art date
Application number
SG1996003050A
Other languages
English (en)
Inventor
Dan L Eaton
De Frederic J Sauvage
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/196,689 external-priority patent/US8357513B1/en
Priority claimed from US08/249,376 external-priority patent/US8192955B1/en
Priority claimed from US08/348,657 external-priority patent/US6660256B1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG47030A1 publication Critical patent/SG47030A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Vehicle Body Suspensions (AREA)
  • Information Transfer Systems (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG1996003050A 1994-01-03 1994-12-21 Thrombopoietin SG47030A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US17655394A 1994-01-03 1994-01-03
US18560794A 1994-01-21 1994-01-21
US08/196,689 US8357513B1 (en) 1994-01-03 1994-02-15 Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
US22326394A 1994-04-04 1994-04-04
US08/249,376 US8192955B1 (en) 1994-01-03 1994-05-25 Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
US34865894A 1994-12-02 1994-12-02
US08/348,657 US6660256B1 (en) 1994-01-03 1994-12-02 Porcine mpl ligand

Publications (1)

Publication Number Publication Date
SG47030A1 true SG47030A1 (en) 1998-03-20

Family

ID=27569151

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996003050A SG47030A1 (en) 1994-01-03 1994-12-21 Thrombopoietin

Country Status (28)

Country Link
EP (1) EP0738323A1 (it)
JP (2) JPH09508262A (it)
CN (1) CN1134539C (it)
AU (1) AU704266B2 (it)
BG (1) BG63639B1 (it)
CA (1) CA2178482C (it)
CZ (1) CZ296130B6 (it)
DK (1) DK149194A (it)
ES (1) ES2114786B1 (it)
FI (1) FI121573B (it)
FR (1) FR2714670B1 (it)
GB (1) GB2285446B (it)
HR (1) HRP941020A2 (it)
HU (1) HUT75657A (it)
IE (1) IE72517B1 (it)
IL (1) IL112184A (it)
IT (1) IT1283770B1 (it)
LU (1) LU88573A1 (it)
LV (1) LV11632B (it)
NL (1) NL9500010A (it)
NO (1) NO326903B1 (it)
NZ (1) NZ278726A (it)
PT (1) PT101627B (it)
RO (1) RO117110B1 (it)
SG (1) SG47030A1 (it)
SI (1) SI9420079A (it)
SK (1) SK282265B6 (it)
WO (1) WO1995018858A1 (it)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
NZ271230A (en) * 1994-02-14 1998-03-25 Zymogenetics Inc Hematopoietic proteins, production and use
DE69503849T2 (de) * 1994-03-31 1999-04-01 Amgen Inc., Thousand Oaks, Calif. Zusammensetzungen und Verfahren zur Anregung des Wachstums und der Differenzierung von Megakaryozyten
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
US5986049A (en) * 1994-12-30 1999-11-16 Zymogenetics, Inc. Purified thrombopoietin and method of making it
TW387940B (en) * 1995-01-17 2000-04-21 Kirin Brewery Anti-tpo monodonal antibody
US6254870B1 (en) 1995-02-03 2001-07-03 G. D. Searle & Co. Thrombopoietin: IL-3 fusion protein
US5696250A (en) 1995-02-15 1997-12-09 Amgen Inc. DNA encoding megakaryocyte growth and development factor analogs
US5989538A (en) * 1995-02-15 1999-11-23 Amgen Inc. Mpl ligand analogs
CA2209298C (en) * 1995-02-15 2001-12-18 Amgen Inc. Mpl ligand analogs
TW434020B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
TW434021B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
ZA964382B (en) * 1995-06-06 1997-12-01 Genentech Inc Lymphotoxin and thrombopoietin for use in the treatment of cancer.
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
EA001220B1 (ru) 1995-06-07 2000-12-25 Глаксо Груп Лимитед Пептид или пептидомиметик, который связывается с рецептором тромбоэтина, фармацевтическая композиция и способ лечения
TW497972B (en) * 1995-06-08 2002-08-11 Kirin Brewery Stable thrombopoietin (TPO)-containing lyophilized compositions
US6066318A (en) 1995-10-05 2000-05-23 G.D. Searle & Co. Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
US6031071A (en) * 1996-01-24 2000-02-29 Biophage, Inc. Methods of generating novel peptides
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
EP0920511A1 (en) * 1996-08-13 1999-06-09 ZymoGenetics Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
JP4562815B2 (ja) * 1997-05-21 2010-10-13 ジェネンテック， インコーポレイテッド トロンボポエチンの新規な投与
US5980893A (en) * 1997-07-17 1999-11-09 Beth Israel Deaconess Medical Center, Inc. Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis
US6342220B1 (en) 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
US20030228666A1 (en) 1998-06-30 2003-12-11 Daewoong Pharmaceutical Co., Ltd. Novel human thrombopoietin mutein
KR20000006549A (ko) * 1998-06-30 2000-01-25 윤재승 생체내혈소판증식효능이향상된신규한트롬보포이에틴유도체
HK1042114B (zh) 1998-10-23 2006-09-29 Amgen K-A, Inc. 与mp1受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
CY2010012I2 (el) * 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
UY26317A1 (es) * 2000-08-30 2000-10-31 Alfonso Cayota Carlos Pritsch Sistema de produccion de trombopoyetina humana por celulas de mamiferos en cultivo
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
US7332474B2 (en) 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
WO2003041495A1 (en) 2001-11-15 2003-05-22 Kirin Beer Kabushiki Kaisha Chimeric nonhuman animal
KR100467750B1 (ko) * 2001-11-29 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
CA2499625A1 (en) 2002-09-18 2004-04-01 Ortho-Mcneil Pharmaceutical, Inc. Methods of increasing platelet and hematopoietic stem cell production
UA82710C2 (uk) 2003-08-28 2008-05-12 Орто-Макнейл Фармацевтикал, Инк. Пептид, що зв'язується з тромбопоетиновим рецептором (варіанти), та спосіб лікування тромбоциторенії (варіанти)
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
EP1751298A4 (en) 2004-05-18 2009-11-11 Intrexon Corp METHOD FOR DYNAMIC VECTOR ASSEMBLY OF DNA CLONING VECTOR PLASMIDES
CA2572765C (en) 2004-07-08 2013-05-21 Amgen Inc. Compound having improved bioefficiency when administered in a multidose regimen
US7442778B2 (en) 2004-09-24 2008-10-28 Amgen Inc. Modified Fc molecules
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9012605B2 (en) 2006-01-23 2015-04-21 Amgen Inc. Crystalline polypeptides
WO2007098547A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
US7981425B2 (en) 2006-06-19 2011-07-19 Amgen Inc. Thrombopoietic compounds
AU2007278748B2 (en) 2006-07-24 2013-08-15 The University Of Queensland Method of producing a population of cells
TW200902708A (en) 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
EP2738257A1 (en) 2007-05-22 2014-06-04 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
KR101040396B1 (ko) 2009-01-20 2011-06-09 한올바이오파마주식회사 변형된 인간 트롬보포이에틴 폴리펩타이드 절편 및 그의 제조방법
WO2014089478A1 (en) * 2012-12-07 2014-06-12 University Of Tennessee Research Foundation Methods of numerical analysis for platelet disorders and computer-readable media and systems for performing the same
CN114558032B (zh) 2012-12-21 2025-07-29 安斯泰来再生医药协会 由多能干细胞制备血小板的方法及其组合物
CN103555760B (zh) * 2013-10-18 2015-05-20 江苏康禾生物制药有限公司 一种重组人血小板生成素的制备方法及其制剂
WO2017111215A1 (ko) * 2015-12-21 2017-06-29 주식회사 브레인온 기억력, 학습력, 인지력 향상용 조성물
GB201700621D0 (en) 2017-01-13 2017-03-01 Guest Ryan Dominic Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
AU2020349991A1 (en) * 2019-09-20 2022-04-07 Ractigen Therapeutics Nucleic acid molecule for treating immune thrombocytopenia and application thereof
KR20220119439A (ko) 2019-12-20 2022-08-29 인스틸 바이오 유케이 리미티드 종양 침윤 림프구를 분리하기 위한 장치 및 방법 및 그것의 용도
CN118086536A (zh) * 2024-04-23 2024-05-28 佛山科学技术学院 一种通过snp标记改善黄牛血小板生成素分泌的方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260417A (en) 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
ATE204606T1 (de) * 1991-12-06 2001-09-15 Genentech Inc Prohormon konvertase transformierte zellen.
IL139335A (en) 1994-01-03 2005-08-31 Genentech Inc Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia

Also Published As

Publication number Publication date
SK87596A3 (en) 1997-11-05
SI9420079A (en) 1997-02-28
CA2178482C (en) 2012-01-03
CZ192296A3 (en) 1997-05-14
LV11632B (en) 1997-04-20
EP0738323A1 (en) 1996-10-23
CA2178482A1 (en) 1995-07-13
NZ278726A (en) 1998-06-26
NO962783D0 (no) 1996-07-02
GB2285446B (en) 1999-07-28
CN1134539C (zh) 2004-01-14
SK282265B6 (sk) 2001-12-03
GB2285446A (en) 1995-07-12
IE72517B1 (en) 1997-04-23
IE950002A1 (en) 1995-07-12
CN1141061A (zh) 1997-01-22
RO117110B1 (ro) 2001-10-30
IL112184A (en) 2004-07-25
JPH09508262A (ja) 1997-08-26
NL9500010A (nl) 1995-08-01
HUT75657A (en) 1997-05-28
FI962723A0 (fi) 1996-07-02
LV11632A (lv) 1996-12-20
AU1514695A (en) 1995-08-01
NO326903B1 (no) 2009-03-16
JPH10113186A (ja) 1998-05-06
WO1995018858A1 (en) 1995-07-13
DK149194A (da) 1995-07-04
NO962783L (no) 1996-09-03
IL112184A0 (en) 1995-03-15
FR2714670B1 (fr) 1997-01-10
ES2114786B1 (es) 1999-01-01
LU88573A1 (de) 1995-06-01
PT101627A (pt) 1995-11-30
FI962723L (fi) 1996-09-03
GB9425831D0 (en) 1995-02-22
FR2714670A1 (fr) 1995-07-07
AU704266B2 (en) 1999-04-15
HU9601805D0 (en) 1996-08-28
HRP941020A2 (en) 1997-04-30
ES2114786A1 (es) 1998-06-01
BG63639B1 (bg) 2002-07-31
PT101627B (pt) 1996-11-29
FI121573B (fi) 2011-01-14
ITTO950002A0 (it) 1995-01-02
BG100693A (en) 1998-01-30
IT1283770B1 (it) 1998-04-30
ITTO950002A1 (it) 1996-07-02
CZ296130B6 (cs) 2006-01-11

Similar Documents

Publication Publication Date Title
GB2285446B (en) Thrombopoietin
DE69531947D1 (en) Ausbreitbare ringprothese
DE69504528D1 (en) Quenchkühler
GB2296033B (en) Handleset
DE69429543D1 (en) Koagulationszange
ZA9510757B (en) Restricted 9-cis-retinolds
GB9414164D0 (en) Drillclamp
IL139335A0 (en) Thrombopoietin
GB9426485D0 (en) Brickshore
DE69508761D1 (en) Haloalkylierungsverfahren
ZA9410355B (en) Thrombopoietin
DE69504062D1 (en) Spandexlieferspule
GB9419500D0 (en) Stormtent
GR1002005B (en) Thrombopoietin.
AU124030S (en) Member
GB9402499D0 (en) Altered abtibodies
GB9426260D0 (en) De-racemisation
GB9501795D0 (en) Brickshore
GB9419340D0 (en) Aminocheterocycles
AU121664S (en) Gamesboard
GB9422577D0 (en) Sportsview
GB9403978D0 (en) Aqua-ramp
PL302014A1 (en) Brief-case
GB9422036D0 (en) Ergocom
GB9402303D0 (en) Lamatile